Adjunctive Kinesiotaping in Surgical Treatment of Impacted Mandibular Third Molars

January 5, 2026 updated by: Medical University of Silesia

Application of Kinesiotaping as an Adjunctive Physiotherapeutic Method in the Surgical Management of Impacted Mandibular Third Molars

PATIENT INFORMATION SHEET Participants are invited to take part in a clinical study involving surgical removal of an impacted lower wisdom tooth. Participation in this study is entirely voluntary.

The purpose of this study is to observe the healing process after wisdom tooth removal and to assess whether the use of elastic therapeutic tape placed on the skin (kinesiotaping) may support recovery.

SURGICAL PROCEDURE The procedure will be performed under local anesthesia and will include: - Administration of local anesthesia

  • Incision of the gum
  • Exposure of the impacted tooth and surrounding bone
  • Removal of the tooth
  • Cleaning of the surgical site - Placement of sutures After the surgery, standard post■operative instructions will be provided. STUDY PROCEDURE

After the surgical procedure, patients will be randomly assigned to one of two groups:

  1. Standard post■operative care
  2. Post■operative care combined with application of elastic therapeutic tape on the skin of the face and neck area If the participants are assigned to the tape group, the tape will be applied immediately after surgery by qualified medical personnel and will remain in place for several days.

FOLLOW■UP VISITS Participant will be asked to attend follow■up visits on specific days after the procedure to allow the medical team to assess healing. PAIN MANAGEMENT Participant will be allowed to take pain medication if necessary, following medical advice.

VOLUNTARY PARTICIPATION Participation in this study is voluntary. Participant may withdraw from the study at any time without giving a reason and without affecting participants medical care.

CONFIDENTIALITY All medical information collected during the study will be handled confidentially and used solely for research purposes.

Study Overview

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Silesian Voivodeship
      • Bytom, Silesian Voivodeship, Poland, 41-902
        • Uniwersyteckie centrum stomatologii

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • No systemic diseases (generally healthy patient)

Indication for surgical extraction of impacted lower third molars for:

orthodontic reasons

surgical reasons

prophylactic reasons

Age between 16 and 64 years

Written informed consent to participate in the study

Exclusion Criteria:

  • Presence of chronic systemic diseases, including:

diabetes mellitus

hypertension

autoimmune diseases

Pharmacological treatment in the period preceding the surgery

Pregnancy

Substance abuse or dependence

Head and neck malignancies

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Research group
Group undergoing Kinesiotaping after the surgical procedure
basic lymphatic KT application
basic surgical extraction
Other: Control Group
no kinesiotaping
basic surgical extraction

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
postoperative pain intensity
Time Frame: 2 days post-surgery and 7 days post-surgery
Postoperative pain intensity will be assessed using the Visual Analog Scale (VAS), ranging from 0 to 10, where 0 indicates no pain and 10 indicates the worst pain imaginable. Higher scores indicate greater pain intensity.
2 days post-surgery and 7 days post-surgery
Maximum Mouth Opening (MMO)
Time Frame: FinishBefore surgery, 2 days after surgery, and 7 days after surgery
Maximum mouth opening will be measured using a caliper as the interincisal distance between the upper and lower incisors at maximum mouth opening.
FinishBefore surgery, 2 days after surgery, and 7 days after surgery
Facial Soft Tissue Swelling
Time Frame: Before surgery, 2 days after surgery, and 7 days after surgery
Facial swelling will be assessed using linear tape measurements between six predefined facial reference points. The sum of distances will be used for analysis.
Before surgery, 2 days after surgery, and 7 days after surgery
Postoperative Analgesic Consumption
Time Frame: Day of surgery, 2 days after surgery, and 7 days after surgery
The total number of ketoprofen 100 mg tablets taken by each participant will be recorded as a measure of postoperative analgesic demand.
Day of surgery, 2 days after surgery, and 7 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 14, 2023

Primary Completion (Actual)

December 2, 2025

Study Completion (Actual)

December 8, 2025

Study Registration Dates

First Submitted

December 9, 2025

First Submitted That Met QC Criteria

January 5, 2026

First Posted (Estimated)

January 12, 2026

Study Record Updates

Last Update Posted (Estimated)

January 12, 2026

Last Update Submitted That Met QC Criteria

January 5, 2026

Last Verified

January 1, 2026

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • BNW/NWN/0052/KB1/57/I/23

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Impacted Third Molar Tooth

Clinical Trials on Kinesiotaping

Subscribe